Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR

Journal of Medicinal Chemistry

Volumn 48, Issue 2, 2005, Pages 523-533

  Grace, Christy Rani R ^a   Durrer, Lukas ^a   Koerber, Steven C ^a   Erchegyi, Judit ^a   Reubi, Jean Claude ^b   Rivier, Jean E ^a   Riek, Roland ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5;

ARTICLE; BINDING AFFINITY; DRUG CONFORMATION; DRUG RECEPTOR BINDING; NUCLEAR MAGNETIC RESONANCE; PHARMACOPHORE; PROTEIN MOTIF; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 12344288009     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049518u     Document Type: Article

References (46)

1. α-methylated scan. J. Med. Chem. 2005, 48, 507-514.
2. Rivier, J.; Kirby, D.; Erchegyi, J.; Waser, B.; Eltschinger, V.; et al. Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides. J. Med. Chem. 2005, 48, 515-522.
3. Reichlin, S. Somatostatin. N. Engl. J. Med. 1983, 309, 1495-1501.
4. Reichlin, S. Somatostatin (second of two parts). N. Engl. J. Med. 1983, 309, 1556-1563.
5. Delfs, J. R.; Dichter, M. A. Effects of somatostatin on mammalian cortical neurons in culture: physiological actions and unusual dose response characteristics. J. Neurosci. 1983, 3, 1176-1188.
6. Iversen, L. L. Nonopioid neuropeptides in mammalian CNS. Annu. Rev. Pharmacol. Toxicol. 1983, 23, 1-27.
7. 4-selective somatostatin (SRIF) agonists. Part I: Lead identification using a betide scan. J. Med. Chem. 2003, 46, 5579-5586.
8. 4-selective somatostatin (SRIF) agonists. Part II: Analogues with β-methyl-3-(2-naphthyl)-alanine substitutions at position 8. J. Med. Chem. 2003, 46, 5587-5596.
9. 4-selective somatostatin (SRIF) agonists. Part III: Analogues amenable to radiolabeling. J. Med. Chem. 2003, 46, 5597-5605.
10. Lewis, I.; Bauer, W.; Albert, R.; Chandramouli, N.; Pless, J. et al. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. J. Med. Chem. 2003, 46, 2334-2344.
11. Reubi, J. C.; Eisenwiener, K. P.; Rink, H.; Waser, B.; Macke, H. R. A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors. Eur. J. Pharmacol. 2002, 456, 45-49.
12. Janecka, A.; Zubrzycka, M.; Janecki, T. Review: Somatostatin analogs. J. Pept. Res. 2001, 58, 91-107.
13. Rivier, J. E.; Hoeger, C.; Erchegyi, J.; Gulyas, J.; DeBoard, R. et al. Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1). J. Med. Chem. 2001, 44, 2238-2246.
14. Reubi, J. C.; Schaer, J.-C.; Wenger, S.; Hoeger, C.; Erchegyi, J. et al. SST3-selective potent peptidic somatostatin receptor antagonists. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 13973-13978.
15. Vale, W.; Rivier, C.; Brown, M.; Rivier, J. Pharmacology of TRF, LRF and somatostatin. Hypothalamic Peptide Hormones and Pituitary Regulation: Advances in Experimental Medicine and Biology; Plenum Press: New York, 1977; pp 123-156.
16. Vale, W.; Rivier, J.; Ling, N.; Brown, M. Biologic and immunologic activities and applications of somatostatin analogs. Metabolism 1978, 27, 1391-1401.
17. Veber, D. F.; Freidinger, R. M.; Perlow, D. S.; Paleveda, W. J., Jr.; Holly, F. W. et al. A potent cyclic hexapeptide analogue of somatostatin. Nature 1981, 292, 55-58.
18. Pohl, E.; Heine, A.; Sheldrick, G. M.; Dauter, Z.; Wilson, K. S. et al. Structure of octreotide, a somatostatin analogue. Acta Crystallogr. 1995, D51, 48-59.
19. Veber, D. F. Design and discovery in the development of peptide analogs. Twelfth American Peptide Symposium; Peptides: Chemistry and Biology: Cambridge, MA, June 16-21, 1991; pp 1-14.
20. Falb, E.; Salitra, Y.; Yechezkel, T.; Bracha, M.; Litman, P. et al. A bicyclic and hsst2 selective somatostatin analogue: design, synthesis, conformational analysis and binding. Bioorg. Med. Chem. 2001, 9, 3255-3264.
21. Jiang, S.; Gazal, S.; Gelerman, G.; Ziv, O.; Karpov, O. et al. A bioactive somatostatin analogue without a type II′ beta-turn: synthesis and conformational analysis in solution. J. Pept. Sci. 2001, 7, 521-528.
22. Nattern, R.-H.; Moore, S. B.; Tran, T.-A.; Rueter, J. K.; Goodman, M. Synthesis, biological activities and conformational studies of somatostatin analogues. Tetrahedron 2000, 56, 9819-9831.
23. 4-selective somatostatin (SRIF) agonists. Part IV: Three-dimensional consensus structure by NMR. J. Med. Chem. 2003, 46, 5606-5618.
24. Nicolaou, K. C.; Salvino, J. M.; Raynor, K.; Pietranico, S.; Reisine, T. et al. Design and synthesis of a peptidomimetic employing β-D-glucose for scaffolding. Peptides - Chemistry, Structure and Biology; ESCOM Science Publishers B. V.: Leiden, The Netherlands, 1990; pp 881-884.
25. Güntert, P.; Mumenthaler, C.; Wüthrich, K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 1997, 273, 283-298.
26. Hagler, A. T.; Dauber, P.; Osguthorpe, D. J.; Hempel, J. C. Dynamics and conformational energetics of a peptide hormone: vasopressin. Science 1985, 227, 1309-1315.
27. Melacini, G.; Zhu, Q.; Goodman, M. Multiconformational NMR analysis of sandostatin (octreotide): Equilibrium between β-sheet and partially helical structures. Biochemistry 1997, 36, 1233-1241.
28. Huang, Z.; He, Y.; Raynor, K.; Tallent, M.; Reisine, T. et al. Side chain chiral methylated somatostatin analog synthesis and conformational analysis. J. Am. Chem. Soc. 1992, 114, 9390-9401.
29. Melacini, G.; Zhu, Q.; Osapay, G.; Goodman, M. A refined model for the somatostatin pharmacophore: Conformational analysis of lanthionine-sandostatin analogs. J. Med. Chem. 1997, 40, 2252-2258.
30. Ankersen, M.; Crider, M.; Liu, S.; Ho, B.; Andersen, H. S. et al. Discovery of a novel non-peptide somatostatin agonist with SST4 selectivity. J. Am. Chem. Soc. 1998, 120, 1368-1373.
31. 4 selectivity: Synthesis and structure-activity relationships of thioureas. J. Med. Chem. 1998, 41, 4693-4705.
32. Rohrer, S. P.; Birzin, E. T.; Mosley, R. T.; Berk, S. C.; Hutchins, S. M. et al. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 1998, 282, 737-740.
33. Prasad, V.; Birzin, E. T.; McVaugh, C. T.; Van Rijn, R. D.; Rohrer, S. P. et al. Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents. J. Med. Chem. 2003, 46, 1858-1869.
34. 1H NMR spectra via two-dimensional homonuclear Hartmann-Hahn spectroscopy. J. Am. Chem. Soc. 1985, 107, 2820-2821.
35. Braunschweiler, L.; Ernst, R. R. Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy. J. Magn. Reson. 1983, 53, 521-528.
36. Ranee, M.; Sorensen, O. W.; Bodenhausen, B.; Wagner, G.; Ernst, R. R. et al. Improved spectral resolution in COSY1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 1983, 117, 479-485.
37. Kumar, A.; Wagner, G.; Ernst, R. R.; Wüthrich, K. Buildup rates of the nuclear Overhauser effect measured by two-dimensional proton magnetic resonance spectroscopy: Implications for studies of protein conformation. J. Am. Chem. Soc. 1981, 103, 3654-3658.
38. Macura, S.; Ernst, R. R. Elucidation of cross-relaxation in liquids by two-dimensional NMR spectroscopy. Mol. Phys. 1980, 41, 95-117.
39. Macura, S.; Huang, Y.; Suter, D.; Ernst, R. R. Two-dimensional chemical exchange and cross-relaxation spectroscopy of coupled nuclear spins. J. Magn. Reson. 1981, 43, 259-281.
40. Güntert, P.; Dotsch, V.; Wider, G.; Wüthrich, K. Processing of multidimensional NMR data with the new software PROSA. J. Biolmol. NMR 1992, 2, 619-629.
41. Eccles, C.; Güntert, P.; Billeter, M.; Wüthrich, K. Efficient analysis of protein 2D NMR spectra using the software package EASY. J. Biomol. NMR 1991, 1, 111-130.
42. Wüthrich, K. NMR of Proteins and Nucleic Acids; J. Wiley & Sons: New York, 1986.
43. Maple, J. R.; Thacher, T. S.; Dinur, U.; Hagler, A. T. Biosym force field research results in new techniques for the extraction of inter- and intramolecular forces. Chem. Design Auto. News 1990, 5, 5-10.
44. Koerber, S. C.; Rizo, J.; Struthers, R. S.; Rivier, J. E. Consensus bioactive conformation of cyclic GnRH antagonists defined by NMR and molecular modeling. J. Med. Chem. 2000, 43, 819-828.
45. Hagler, A. T. Theoretical simulation of conformation, energetics and dynamics of peptides. The Peptides: Analysis, Synthesis, Biology; Academic Press: Orlando, FL, 1985; pp 213-299.
46. Koradi, R.; Billeter, M. MOLMOL: a program for display and analysis of macromolecular structures. PDB Newsletter 1998, 84, 5-7.